Methodologies for localizing loco-regional hypopharyngeal carcinoma recurrences in relation to FDG-PET positive and clinical radiation therapy target volumes

References

• Breen SL, Publicover J, De SS, Pond G, Brock K, O'Sullivan B, . Intraobserver and interobserver variability in GTV delineation on FDG-PET-CT images of head and neck cancers. Int J Radiat Oncol Biol Phys 2007;68:763–70.
   PubMed Web of Science ®Google Scholar
• Chao KS, Bhide S, Chen H, Asper J, Bush S, Franklin G, . Reduce in variation and improve efficiency of target volume delineation by a computer-assisted system using a deformable image registration approach. Int J Radiat Oncol Biol Phys 2007;68:1512–21.
   PubMed Web of Science ®Google Scholar
• Bussels B, Maes A, Hermans R, Nuyts S, Weltens C, Van den BW. Recurrences after conformal parotid-sparing radiotherapy for head and neck cancer. Radiother Oncol 2004; 72:119–27.
   PubMedGoogle Scholar
• Caudell JJ, Meredith RF, Spencer SA, Keene KS, Dobelbower MC, Bonner JA. Margin on gross tumor volume and risk of local recurrence in head-and-neck cancer. Int J Radiat Oncol Biol Phys 2010;76:164–8.
   PubMed Web of Science ®Google Scholar
• Daly ME, Lieskovsky Y, Pawlicki T, Yau J, Pinto H, Kaplan M, . Evaluation of patterns of failure and subjective salivary function in patients treated with intensity modulated radiotherapy for head and neck squamous cell carcinoma. Head Neck 2007;29:211–20.
   PubMed Web of Science ®Google Scholar
• Daly ME, Le QT, Maxim PG, Loo BW, Jr., Kaplan MJ, Fischbein NJ, . Intensity-modulated radiotherapy in the treatment of oropharyngeal cancer: Clinical outcomes and patterns of failure. Int J Radiat Oncol Biol Phys 2010; 76:1339–46.
   PubMed Web of Science ®Google Scholar
• Dawson LA, Anzai Y, Marsh L, Martel MK, Paulino A, Ship JA, . Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 2000;46:1117–26.
   PubMed Web of Science ®Google Scholar
• Eisbruch A, Marsh LH, Dawson LA, Bradford CR, Teknos TN, Chepeha DB, . Recurrences near base of skull after IMRT for head-and-neck cancer: Implications for target delineation in high neck and for parotid gland sparing. Int J Radiat Oncol Biol Phys 2004;59:28–42.
   PubMed Web of Science ®Google Scholar
• Lee N, Xia P, Fischbein NJ, Akazawa P, Akazawa C, Quivey JM. Intensity-modulated radiation therapy for head-and-neck cancer: The UCSF experience focusing on target volume delineation. Int J Radiat Oncol Biol Phys 2003;57:49–60.
   PubMed Web of Science ®Google Scholar
• Sanguineti G, Gunn GB, Endres EJ, Chaljub G, Cheruvu P, Parker B. Patterns of locoregional failure after exclusive IMRT for oropharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2008;72:737–46.
   PubMedGoogle Scholar
• Schoenfeld GO, Amdur RJ, Morris CG, Li JG, Hinerman RW, Mendenhall WM. Patterns of failure and toxicity after intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 2008;71:377–85.
   PubMed Web of Science ®Google Scholar
• Soto DE, Kessler ML, Piert M, Eisbruch A. Correlation between pretreatment FDG-PET biological target volume and anatomical location of failure after radiation therapy for head and neck cancers. Radiother Oncol 2008;89:13–8.
   PubMed Web of Science ®Google Scholar
• Studer G, Luetolf UM, Glanzmann C. Locoregional failure analysis in head-and-neck cancer patients treated with IMRT. Strahlenther Onkol 2007;183:417–23.
   PubMedGoogle Scholar
• Yao M, Dornfeld KJ, Buatti JM, Skwarchuk M, Tan H, Nguyen T, . Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma—the University of Iowa experience. Int J Radiat Oncol Biol Phys 2005;63: 410–21.
   PubMedGoogle Scholar
• DAHANCA guidelines. Available from: http://www.dahanca.dk/guidelines. May 1, 2010.
   Google Scholar
• Hermans R. Posttreatment imaging in head and neck cancer. Eur J Radiol 2008;66:501–11.
   PubMed Web of Science ®Google Scholar
• Chao KSC, Ozyigit G, Tran BN, Cengiz M, Dempsey JF, Low DA. Patterns of failure in patients receiving definitive and postoperative IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys 2003;55:312–21.
   PubMed Web of Science ®Google Scholar
• Bentzen SM, Rosenthal DI, Weymuller EA, Trotti A. Increasing toxicity in nonoperative head and neck cancer treatment: Investigations and interventions. Int J Radiat Oncol Biol Phys 2007;69:S79–S82.
   PubMed Web of Science ®Google Scholar
• Bentzen SM, Trotti A. Evaluation of early and late toxicities in chemoradiation trials. J Clin Oncol 2007;25:4096–103.
   PubMed Web of Science ®Google Scholar
• Assenholt MS, Petersen JB, Nielsen SK, Lindegaard JC, Tanderup K. A dose planning study on applicator guided stereotactic IMRT boost in combination with 3D MRI based brachytherapy in locally advanced cervical cancer. Acta Oncol 2008;47:1337–43.
   PubMed Web of Science ®Google Scholar
• Bentzen SM. Theragnostic imaging for radiation oncology: Dose-painting by numbers. Lancet Oncol 2005;6:112–7.
   PubMed Web of Science ®Google Scholar
• Christian N, Lee JA, Bol A, De BM, Jordan B, Gregoire V. The limitation of PET imaging for biological adaptive-IMRT assessed in animal models. Radiother Oncol 2009;91:101–6.
   PubMed Web of Science ®Google Scholar
• Kim Y, Tome WA. Is it beneficial to selectively boost high-risk tumor subvolumes? A comparison of selectively boosting high-risk tumor subvolumes versus homogeneous dose escalation of the entire tumor based on equivalent EUD plans. Acta Oncol 2008;47:906–16.
   PubMed Web of Science ®Google Scholar
• Ling CC, Humm J, Larson S, Amols H, Fuks Z, Leibel S, Koutcher JA. Towards multidimensional radiotherapy (MD-CRT): Biological imaging and biological conformality. Int J Radiat Oncol Biol Phys 2000;47:551–60.
   PubMed Web of Science ®Google Scholar
• Toma-Dasu I, Dasu A, Brahme A. Dose prescription and optimisation based on tumour hypoxia. Acta Oncol 2009; 48:1181–92.
   PubMed Web of Science ®Google Scholar